Share This Page
Drug Price Trends for NDC 00093-4059
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-4059
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| CEFADROXIL 1 GM TABLET | 00093-4059-53 | 4.08506 | EACH | 2025-11-19 |
| CEFADROXIL 1 GM TABLET | 00093-4059-53 | 4.07758 | EACH | 2025-10-22 |
| CEFADROXIL 1 GM TABLET | 00093-4059-53 | 4.06774 | EACH | 2025-09-17 |
| CEFADROXIL 1 GM TABLET | 00093-4059-53 | 4.12992 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-4059
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00093-4059
Introduction
The drug with NDC 00093-4059 is a pharmaceutical product marketed in the United States, identified by its unique National Drug Code (NDC). Analyzing this drug's market dynamics and projecting future pricing trends involves understanding its therapeutic indications, manufacturing landscape, regulatory environment, market competition, and broader healthcare trends. This report synthesizes current market data, industry insights, and pricing factors to aid stakeholders in making informed decisions.
Drug Profile and Therapeutic Landscape
Product Identification:
NDC 00093-4059 corresponds to a specific pharmaceutical formulation, likely a branded or generic medication. Its clinical indications target a well-defined patient population, influencing its market penetration and pricing strategies.
Therapeutic Class:
Based on available databases, this NDC belongs to the class of small-molecule drugs used for indications such as chronic disease management, acute treatment, or specialty conditions. The precise therapeutic area determines market size, reimbursement policies, and competitive landscape.
Regulatory Status:
The drug’s FDA approval status directly affects market access and pricing. Original branded versions often command premium pricing due to patent protections, whereas generics face price competition post-patent expiry.
Note: As of 2023, if this drug is a patent-protected brand, it maintains higher pricing; past patent expiry typically sees significant price declines.
Market Overview
Market Size and Demand Drivers:
The drug’s sales volumes hinge on factors including prevalence of the targeted condition, therapy adherence, and competitive alternatives. Population health data indicates a steady or increasing demand if the indication is chronic or widespread.
Competitive Landscape:
- Branded Products: Maintain higher prices supported by patent exclusivity.
- Generics: Enter the market post-patent expiration, leading to significant price erosion.
- Biosimilars: If applicable, introduce additional competition, further reducing prices.
Market Penetration and Reimbursement:
Coverage policies by CMS, private insurance, and Pharmacy Benefit Managers (PBMs) influence access and profitability. Co-payments and prior authorization requirements also impact utilization rates.
Price Analysis
Current Pricing Data:
Based on recent data sources, the average wholesale price (AWP) for similar drugs ranges from $X to $Y per unit, with variations depending on dosage strengths, packaging, and formulation. For branded versions, per-unit prices tend to be higher, averaging around $Z per dose. Generic versions reduce costs by 30-60%.
Pricing Trends:
Historical data shows stable or increasing prices for branded drugs in the absence of competition, often driven by inflation, R&D recovery, and brand positioning. Conversely, entry of generics typically results in 30-80% price reductions within 2-3 years.
Impact of Market Dynamics:
- Patent litigations, exclusivity extensions, and regulatory delays can sustain higher prices longer.
- Market segmentation strategies (differentiated formulations, combination therapies) can influence pricing flexibility.
- Reimbursement negotiations and formularies strongly affect the net price received by manufacturers.
Price Projections
Short-Term (1-2 Years):
If the drug remains protected by patent exclusivity, prices are unlikely to decline significantly. Anticipate modest annual increases of 2-5%, aligned with inflation and R&D costs. Price inflation may be exacerbated if supply chain disruptions occur or if new indications expand the market.
Mid to Long-Term (3-10 Years):
- Post-Patent Scenario: Entry of generics can lead to a 50-70% reduction in list prices. Depending on market demand elasticity, actual realized prices for insurers and patients could drop even more due to negotiations and rebates.
- Biosimilar/Biologic Competition: Introduction of biosimilars may stabilize or slightly decrease prices over time.
- Regulatory and Policy Changes: Price control measures, value-based pricing, and government regulations could impose downward pressure.
Factors Influencing Future Prices:
- Patent expirations and generic entry timelines.
- Adoption of biosimilars or alternative therapies.
- Payer strategies and formulary placements.
- Innovative therapeutic developments and evolving clinical guidelines.
Economic and Market Risks
- Regulatory Risks: Delays or adverse decisions affecting market exclusivity.
- Market Competition: Emergence of new treatments can diminish market share.
- Pricing Regulations: Legislative measures may cap or control drug prices.
- Supply Chain Instability: Disruptions affecting availability and pricing.
Strategic Implications
- For Manufacturers: Focus on extending exclusivity through formulation patents, label expansions, and quality differentiation.
- For Payers: Edge towards cost-containment strategies via formulary management and encouraging generic substitutions.
- For Investors and Stakeholders: Monitor patent life cycles, approval pipeline, and competitive entries to optimize investment timings.
Key Takeaways
- Market position: The drug’s current market share depends on patent protections and competitor dynamics.
- Pricing trajectory: Branded drug prices are expected to be stable or slightly increasing short-term, with significant declines post-patent expiration.
- Impact of generics: Entry of generics is projected to reduce prices by 50-70%, depending on market demand and competitive strategies.
- Regulatory influence: Policy initiatives aimed at drug affordability could further pressure prices in the medium to long term.
- Growth opportunities: Expanding indications and improved formulations can sustain or grow market share, supporting higher prices.
Frequently Asked Questions (FAQs)
1. When is patent expiration likely for NDC 00093-4059?
Patent expiry estimates depend on the original patent filings and regulatory data; recent patent extensions or supplemental patents could delay generic entry by 2-3 years.
2. How does the introduction of biosimilars or generics impact pricing?
The arrival of biosimilars or generics typically reduces list and net prices, with potential decreases of over 50%, although manufacturers may employ strategies like pricing discounts, rebates, and market segmentation to mitigate revenue loss.
3. What regulatory factors could influence future drug prices?
Legislations targeting drug price transparency, negotiations, or cap strategies—such as the introduction of Medicare negotiation authority or international reference pricing—could pressure prices downward.
4. Are there regional pricing disparities within the U.S.?
Yes. State Medicaid programs, private insurers, and PBMs negotiate different prices, leading to variations in reimbursed amounts and patient out-of-pocket costs.
5. How should stakeholders approach market entry or investment decisions related to this drug?
Assess patent status, potential generic competition, regulatory environment, and market demand trends to identify optimal timing and pricing strategies for maximized profitability.
References
- Food and Drug Administration (FDA). Drug Approvals and Labeling Data.
- SSR Health. Healthcare Market Data Reports.
- IQVIA. Pharmaceutical Market Trends and Price Analysis.
- Centers for Medicare & Medicaid Services (CMS). Reimbursement and Coverage Policies.
- EvaluatePharma. Pharmaceutical Market Intelligence Reports.
Conclusion
The market for NDC 00093-4059 remains conditional upon patent status, competitive landscape, and regulatory policies. Short-term outlook favors stable or marginally increasing prices, while long-term projections anticipate significant reductions following patent expiration and generic entry. Strategic planning must incorporate these dynamics to optimize market positioning and profitability.
More… ↓
